Schwartz GK - Search Results

1

Drg1, a novel target for modulating sensitivity to CPT-11 in colon cancer cells.

Motwani M, Sirotnak FM, She Y, Commes T, Schwartz GK. Motwani M, et al. Among authors: schwartz gk. Cancer Res. 2002 Jul 15;62(14):3950-5. Cancer Res. 2002. PMID: 12124325

2

Potentiation of apoptosis by treatment with the protein kinase C-specific inhibitor safingol in mitomycin C-treated gastric cancer cells.

Schwartz GK, Haimovitz-Friedman A, Dhupar SK, Ehleiter D, Maslak P, Lai L, Loganzo F Jr, Kelsen DP, Fuks Z, Albino AP. Schwartz GK, et al. J Natl Cancer Inst. 1995 Sep 20;87(18):1394-9. doi: 10.1093/jnci/87.18.1394. J Natl Cancer Inst. 1995. PMID: 7658500

3

A phase II trial of alpha-interferon and 5-fluorouracil in patients with advanced carcinoid and islet cell tumors.

Saltz L, Kemeny N, Schwartz G, Kelsen D. Saltz L, et al. Cancer. 1994 Aug 1;74(3):958-61. doi: 10.1002/1097-0142(19940801)74:3<958::aid-cncr2820740326>3.0.co;2-x. Cancer. 1994. PMID: 8039124 Clinical Trial.

4

Defining the invasive phenotype of proximal gastric cancer cells.

Schwartz GK, Wang H, Lampen N, Altorki N, Kelsen D, Albino AP. Schwartz GK, et al. Cancer. 1994 Jan 1;73(1):22-7. doi: 10.1002/1097-0142(19940101)73:1<22::aid-cncr2820730106>3.0.co;2-o. Cancer. 1994. PMID: 8275429

5

Edatrexate in patients with soft tissue sarcoma. Activity in malignant fibrous histiocytoma.

Casper ES, Christman KL, Schwartz GK, Johnson B, Brennan MF, Bertino JR. Casper ES, et al. Among authors: schwartz gk. Cancer. 1993 Aug 1;72(3):766-70. doi: 10.1002/1097-0142(19930801)72:3<766::aid-cncr2820720321>3.0.co;2-z. Cancer. 1993. PMID: 8392904 Clinical Trial.

6

Protein kinase C: a novel target for inhibiting gastric cancer cell invasion.

Schwartz GK, Jiang J, Kelsen D, Albino AP. Schwartz GK, et al. J Natl Cancer Inst. 1993 Mar 3;85(5):402-7. doi: 10.1093/jnci/85.5.402. J Natl Cancer Inst. 1993. PMID: 8433394

7

A phase I trial of a modified, dose intensive FAMTX regimen (high dose 5-fluorouracil+doxorubicin+high dose methotrexate+leucovorin) with oral uridine rescue.

Schwartz GK, Christman K, Saltz L, Casper E, Quan V, Bertino J, Martin DS, Colofiore J, Kelsen D. Schwartz GK, et al. Cancer. 1996 Nov 1;78(9):1988-95. Cancer. 1996. PMID: 8909321 Clinical Trial.

8

Chemotherapeutically induced DNA damage, ATP depletion, and the apoptotic biochemical cascade.

Martin DS, Schwartz GK. Martin DS, et al. Among authors: schwartz gk. Oncol Res. 1997;9(1):1-5. Oncol Res. 1997. PMID: 9112254

9

UCN-01 suppresses thymidylate synthase gene expression and enhances 5-fluorouracil-induced apoptosis in a sequence-dependent manner.

Hsueh CT, Kelsen D, Schwartz GK. Hsueh CT, et al. Among authors: schwartz gk. Clin Cancer Res. 1998 Sep;4(9):2201-6. Clin Cancer Res. 1998. PMID: 9748140

10

UCN-01 in ovary cancer cells: effective as a single agent and in combination with cis-diamminedichloroplatinum(II)independent of p53 status.

Husain A, Yan XJ, Rosales N, Aghajanian C, Schwartz GK, Spriggs DR. Husain A, et al. Among authors: schwartz gk. Clin Cancer Res. 1997 Nov;3(11):2089-97. Clin Cancer Res. 1997. PMID: 9815601

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

331 results

Search Page

Filters